2008
DOI: 10.1093/rheumatology/ken130
|View full text |Cite
|
Sign up to set email alerts
|

Cancer risk in hospitalized rheumatoid arthritis patients

Abstract: This study, the largest so far published, quantified the increased and decreased site-specific risks of cancer in RA patients. The recent increases in the risks of squamous cell skin and upper aerodigestive tract cancers, melanoma and leukaemia call for continuous vigilance and recording of changes in treatment.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

5
69
2
3

Year Published

2008
2008
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 95 publications
(79 citation statements)
references
References 19 publications
5
69
2
3
Order By: Relevance
“…These tumors have been in large excess in rheumatoid arthritis patients according to one of our recent studies. 26 Nonmelanoma skin cancer was in excess in a previous study on UC patients. 9 …”
Section: Discussionmentioning
confidence: 91%
“…These tumors have been in large excess in rheumatoid arthritis patients according to one of our recent studies. 26 Nonmelanoma skin cancer was in excess in a previous study on UC patients. 9 …”
Section: Discussionmentioning
confidence: 91%
“…This cancer is one of the hallmarks of dysregulated immunity; another hallmark, non-Hodgkin's lymphoma, showed no increase and a decrease in those hospitalised only once. The decrease in endometrial cancer raised the possibility that dysregulated immune function among asthma patients may affect oestrogen production (Ahmed et al, 1999;Hemminki et al, 2008). The only other tumour with a decreased risk was melanoma, but only in asthmatics diagnosed in the 1970s.…”
Section: Discussionmentioning
confidence: 99%
“…AML was also seen more during the first year after diagnosis with a standardized incidence ratio (SIR) of 4.88 for less than one year and 2.03 for 1-4 years. 38 The fourth study analyzed the potential associations between individual DMARDs and the risk of developing hematologic neoplasms. This was a cohort of elderly patients (mean age 61.7 years) linked to the population data base of Quebec.…”
mentioning
confidence: 99%